Prefeasibility Report M/s. SHIV KRISHNA BIOGEN LLP Plot No 7, Survey no .407/15 Paiki, Village-Hadmatiya.Tal-Tankara, Dist-Morbi, Gujarat. 1.0 EXECUTIVE SUMMARY Name of Unit : M/s. SHIV KRISHNA BIOGEN LLP Location of industrial Plot No 7, Survey no .407/15 Paiki, Plant Village-Hadmatiya. Tal-Tankara, Dist-Morbi, Gujarat. Products : Active Pharmaceuticals Ingredient Intermediates- 225.525 MT/Month, Pl ref. Annexure 1 of Form -1 Screening Category : Synthetic Organic Chemicals (Active Pharmaceuticals Ingredient Intermediates) covered under Schedule 5 (f) Category “A” as per EIA notification 2006 and its amendment thereof. [Unit is located outside industrial area and having Water Consumption more than 25 KL/Day] Coordinate of project site : Pl ref Annexure 5.of Form -1 Point Co Ordinates Center point 22°41'2.95"N 70°47'0.01"E A 22°41'4.08"N 70°46'58.76"E B 22°41'3.82"N 70°47'1.49"E C 22°41'3.08"N 70°47'1.41"E D 22°41'1.95"N 70°47'0.38"E E 22°41'2.09"N 70°46'58.53"E F 22°41'2.75"N 70°47'1.48"E Cost of Project : Proposed : 480 Lacs Environment Proposed : 120 Lacs management Plan. Land Area : Proposed: 4479.57 Sq.m Pl ref Annexure 2.of Form -1 Green belt area 1478.25 sq.m Production Capacity : Active Pharmaceuticals Ingredient Intermediates-225.525 MT/Month, Pl ref Annexure 3 of Form -2 Electricity Source : Source : PGVCL Proposed Connected Load : 300 KVA D.G Set :100 KVA (standby source) Source of Water : Borwell. Consumption of Water : A. Domestic : 2.00 KL/Day B. B Industrial: 30.861 KL/Day (Process-19.861KL/Day Cooling- 3.00 KL/Day, Boiler- 5.00 KL/Day, Washing- 3.00 KL/Day ) C. Gardening : 2.00 KL/Day Total (A+B+C): 34.861 KL/Day Pl ref. Annexure : 6 of Form 1 Waste Water Generation : A. Domestic : 1.80 KL/Day B. Industrial : 27.198 KL/Day Process : 23.398 KL/Day , Cooling : 0.3 KL/Day Boiler : 0.500 KL/Day, Washing : 3.00 KL/Day Page No 1 Prefeasibility Report M/s. SHIV KRISHNA BIOGEN LLP Plot No 7, Survey no .407/15 Paiki, Village-Hadmatiya.Tal-Tankara, Dist-Morbi, Gujarat. Total (A+B): 28.998 KL/Day Pl ref. Annexure : 6 for Form 1 Treatment Facility : VOC stripper, Primary treatment followed by Oxidation Process, Reverse Osmosis System and Multi Effect Evaporator. Pl ref. Annexure 7 of Form -1 Mode of Disposal : For domestic w/w : Soak Pit Treated industrial effluent will be treating and evaporated within premises. RO permeate and MEE condensate will be use in industrial purpose. Fuel and Consumption : Briquettes /White Coal : 5 MT/Day, HSD : 60 Lit/Hr Pl ref. Annexure 9 .of Form -1 Source of Flue Gas : Boiler and D.G Set. Pl ref. Annexure 8 of Form -1 Emission Source of Process : HCL Gas emission from process reaction of 1-(2,3 Dichlrophenyl) Emission Piperazine Hydrochloride,Mono Bromo Acetic Acid and 4 Chlro Resorcinol SO2 Gas emission from process reaction of 4 Chlro Resorcinol. Ammonia gas emission from process reaction of Ethylene Urea and Pregabalin. VOC emission from handling solvents. Air Pollution Control : For Process gas emission: Two stage Alkali Scrubber with adequate Measures stack height. For Flue Gas emission.: Multicyclone separator with Bag Filter with adequate stack height. For control of VOC: Solvent recovery system followed by Carbon Column. Proper ventilation and exhaust facility will be provided for control of fugitive emission in work place area. Pl ref. Annexure 8 of Form -1 Type of Hazardous waste : ETP Waste, MEE salt, Process Residue, Date expiry and Off specification generation and mode of product, Discarded Containers, Waste Oil, Spent Acid and inorganic disposal acids. Annexure 5 of Form -1 Mode of disposal of Haz : Generated ETP Waste and MEE Salt will be disposed at authorized TSDF Waste Site. Process Residue and spent carbon will be send to CHWIF. Generated scrubber bleed off (HCL and Liq. Ammonia will be partially use in process and remaining will be sent to actual end users. Sodium Bromide Solution will be send to actual end user. Pl ref. Annexure 5 of Form -1Annexure Employment : Permanent: 5+ Contract: 10 = Total Proposed : 15 Page No 2 Prefeasibility Report M/s. SHIV KRISHNA BIOGEN LLP Plot No 7, Survey no .407/15 Paiki, Village-Hadmatiya.Tal-Tankara, Dist-Morbi, Gujarat. PROPOSED PROJECT WILL HAVE FOLLOWING PRODUCT PROFILE. Table No 1 List of Products with their Production Capacity CAS No Production Sr No Product Name Capacity MT/M 1 1-(2,3 Dichlrophenyl) Piperazine Hydrochloride 119532-26-2 15 2 Ferrous Fumarate 141-01-5 25 3 Mono Bromo Acetic Acid 79-08-3 5 4 Motoprolol 37350-58-6 5 5 Indole-3-Acetic Acid 87-51-4 10 6 4 Chlro Resorcinol 95-88-5 25 7 Ethylene Urea 120-93-4 15 8 Succinimde 123-56-8 25 9 N Bromo Succinimide 128-08-5 25 10 Bronopol 52-51-7 15 11 Mono chloro acetonitrile 107-14-2 0.025 12 Pregabalin 148553-50-8 30 13 Lidocaine Base/HCl 73-78-9 30 14 R & D for Active Pharmaceuticals Ingredients - 0.500 Total 225.525 1.1 Regulatory Compliances & Applicable Laws / Regulations Following will be applicable laws and regulations: 1. The Water (Prevention and Control of Pollution) Act, 1974 (Amended 1988) 2. The Water (Prevention and Control of Pollution) Rules, 1975 3. The Water (Prevention and Control of Pollution) Cess Act, 1977 (Amended 1991) 4. The Water (Prevention and Control of Pollution) Cess Rules, 1978 5. Air (Prevention and Control of Pollution) Act, 1981 (Amended 1987) 6. The Air (Prevention and Control of Pollution) Rules, 1982-83 7. The Environmental (Protection) Rules, 1986 (Amended 1999, 2001, 2002, 2003, 2004) 8. The Environmental (Protection) Act, 1986 (Amended 1991) 9. Hazardous Waste (Management and Handling) Rules, 2016 10. Manufacture, Storage and Import of Hazardous Chemicals Rules, 1989 (Amended 2000) Page No 3 Prefeasibility Report M/s. SHIV KRISHNA BIOGEN LLP Plot No 7, Survey no .407/15 Paiki, Village-Hadmatiya.Tal-Tankara, Dist-Morbi, Gujarat. 11. Chemical Accidents (Emergency Preparedness and Response) Rules, 1996 12. EIA Notification 2006 (Amended 2014) 13. Public Liability Insurance Act, 1991 (Amended 1992) 14. Public Liability Insurance Rules, 1991 (Amended 1993) 15. The Factories Act, 1948 16. The Explosives Act, 1884 17. The Explosives Rules, 1983 18. The Motor Vehicle Act, 1988 19. The Central Motor Vehicle Rules, 1989 2. INTRODUCTION OF THE PROJECT/BACK GROUND INFORMATION 2.1 Identification of Project and project Proponent Proposed Greenfield project is of synthetic organic chemicals covered under Schedule 5 (f) Category “A” as per EIA notification 2006 and its amendment thereof. At present the partners of the company are:- Table No 2. List of Partners Name of Address, Mobile No. Nationality Proprietor Hardik Kamariya Vaibhav Nager Society Indian Sanala Road, Morbi, Tal-Morbi, Dist-Morbi, Gujarat.Mob No+91 8141211400 2.2 Brief description of nature of project The company intent to manufacture API Intermediates: 225.525 T/Month at above stated location which is covered under Schedule 5 (f) Category “A” as per EIA notification 2006 and its amendment. 2.3 Need for the Project and its importance to country and region: The proposed products falls under Category 5(f) as stated in Environment Impact Assessment Notification Published on 14th September, 2006. Further, the location of the proposed project is outside the notified industrial estate and water consumption will be more than 25 KL/Day and proposed unit is also not fall into small unit criteria described Page No 4 Prefeasibility Report M/s. SHIV KRISHNA BIOGEN LLP Plot No 7, Survey no .407/15 Paiki, Village-Hadmatiya.Tal-Tankara, Dist-Morbi, Gujarat. in EIA notification 25th June 2014. Hence, the project proponent has to obtain the EC from the Ministry of Environment, Forest & Climate Change, New Delhi. India with its large talented manpower, cost effective chemical synthesis, legal & financial framework is poised to become sourcing destination of Bulk drug Intermediates & Active Pharmaceutical Ingredients (APIs) and intermediates to the global market. The pharmaceutical industry in India ranks third in the world in terms of volume and contributes 10% to the global pharmaceutical production. According to the Department of Pharmaceuticals, the Indian pharmaceutical industry is pegged at Rs 810 bn, which includes domestic sales and exports. According to the Department of Pharmaceuticals, the sector employs about 340,000 persons and an estimated 400,000 doctors and 300,000 chemists are serving its 1 bn-plus market. In line with the Market Demand, M/S. Shiv Krishna Biogen LLP intent to manufacture API Intermediates with capacity-225.525 MT/Month at above stated proposed site 2.4 Demand - Supply Gap Based on the informal survey of the market with current customers and various traders, it is found that there is a huge potential for the range of the products currently being manufactured and the proposed new products as mentioned in the product list. 2.5 Imported vs. Indigenous Production The products will be price-competitive while quality will be of international standards, which will have acceptability in the export as well as domestic market. 2.6 Export Possibility The unit will explore the possibilities of export the product. 2.7 Employment Generation due to the Project Proposed project will provide direct employment to 05 skilled and 10 unskilled workers from the local area. The manpower requirement for the proposed project is being expected to generate some permanent jobs and secondary jobs for the operation and maintenance of plant.